12/02/2024
6:10 PM | Fulgent Genetics (Subject)
Xie Jian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
6:10 PM | Fulgent Genetics (Subject)
Gao Hanlin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
6:03 PM | Fulgent Genetics (Subject)
Hsieh Ming (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
6:03 PM | Fulgent Genetics (Subject)
Gao Hanlin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
6:04 PM | Fulgent Genetics (Subject)
Xie Jian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
6:17 AM | Fulgent Genetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024
6:10 AM | Fulgent Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
11/01/2024
3:30 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
3:30 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
3:30 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
3:30 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:20 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:21 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:21 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
6:36 PM | Fulgent Genetics (Subject)
Kim Paul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
6:37 PM | Fulgent Genetics (Subject)
Xie Jian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
5:33 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
5:33 PM | Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
5:33 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
5:34 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
7:22 PM | Fulgent Genetics (Subject)
Hsieh Ming (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2024
6:38 AM | Fulgent Genetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2024
6:09 AM | Fulgent Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
3:27 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
3:28 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
3:29 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:22 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:22 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
5:04 PM | Fulgent Genetics (Issuer)
Marsh Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
5:05 PM | Fulgent Genetics (Issuer)
GROVES REGINA E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
5:06 PM | Fulgent Genetics (Issuer)
Nohaile Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
3:29 PM | Fulgent Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:21 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:22 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:34 AM | Fulgent Genetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024
6:05 AM | Fulgent Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
3:35 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
6:07 PM | Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Ming Hsieh Trust (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:26 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:27 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:28 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
We recommended Palantir in 2021, now we’re recommending this... (Ad) My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol |
02/28/2024
6:10 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:11 PM | Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:11 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:12 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:08 AM | Fulgent Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
5:50 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:52 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:55 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:48 PM | Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
6:27 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
6:26 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:01 PM | Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:39 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:21 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:21 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:21 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
